Abstract This review addresses the plausibility of hydrogen sulfide (H2S) therapy for acute lung injury (ALI) and circulatory shock. by contrasting the promising preclinical results to the present clinical reality. The review discusses how the narrow therapeutic window and width. and potentially toxic effects. https://www.campicon.com/